MEAGAN PETERSON: Open Payments
NPI 1447864491 · COVINGTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,879 in 107 payments from 13 companies in 2025. Trend: 2023 $1,186 · 2024 $1,316 · 2025 $1,879
Food & beverage: $1,880
| Company | Payments | Amount |
|---|---|---|
| Neurelis, Inc. | 13 | $276 |
| PFIZER INC. | 21 | $274 |
| Lundbeck LLC | 22 | $268 |
| UCB, Inc. | 12 | $246 |
| SK Life Science, Inc. | 8 | $222 |
| ABBVIE INC. | 11 | $183 |
| Novartis Pharmaceuticals Corporation | 5 | $96 |
| Axsome Therapeutics, Inc. | 4 | $86 |
| GE HEALTHCARE | 3 | $84 |
| Eisai Inc. | 3 | $62 |
Products named: VALTOCO, NURTEC ODT, VYEPTI, Fintepla, QULIPTA, KESIMPTA, Symbravo, Briviact.
Industry payments across LA — which companies pay providers there.
